CELLEX, INC.

Basic Information

104 TW Alexander Drive
Building 20
Research Triangle Park, NC, 27709

http://www.cellex.us

Company Profile

n/a

Additional Details

Field Value
DUNS: 141314521
Hubzone Owned: N
Socially and Economically Disadvantaged: Y
Woman Owned: N
Number of Employees: 5


  1. Point of Care Flu Drug Resistance Test

    Amount: $1,999,981.00

    DESCRIPTION (provided by applicant): The studies from our Phase I SBIR (AI082728-01) demonstrated that it is feasible to develop the proposed assay, a biochemiluminescence assay that uses a novel flu ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. A Novel Influenza Neuraminidase Inhibition Assay

    Amount: $271,035.00

    DESCRIPTION (provided by applicant): The primary goal of the Phase I SBIR projects is to determine the feasibility of a novel neuraminidase assay to be used as an influenza neuraminidase inhibition an ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. A Rapid and Sensitive Flu Virus Test

    Amount: $79,948.00

    Avian influenza is a highly contagious disease that can spread rapidly in a susceptible population. Thus, avian influenza may have devastating effects on the poultry industry. Because of potential int ...

    SBIR Phase I 2008 Department of Agriculture
  4. An Assay for Rapid and Sensitive Flu Virus Detection

    Amount: $196,100.00

    DESCRIPTION (provided by applicant): The specific aims of this Phase I SBIR proposal are to determine the feasibility of a novel detection technology for rapid and sensitive detection of influenza vi ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. An Affinity Column for Influenza Virus Vaccine Manufacturing

    Amount: $224,784.00

    DESCRIPTION (provided by applicant): We have found a polymer that specifically and efficiently binds to influenza viruses. When coupled to a solid support such as magnetic particles or agarose, the po ...

    SBIR Phase I 2007 Department of Health and Human Services
  6. A Reagent for Rapid and Effective Virus Isolation and Concentration

    Amount: $173,396.00

    DESCRIPTION (provided by applicant): Current global efforts to confront the HIV/AIDS epidemic focus on the prevention of new infections and the care for those who are living with HIV. Highly active a ...

    SBIR Phase I 2007 Department of Health and Human Services
  7. A Novel Method for Efficient and Specific Nucleic Acid Isolation

    Amount: $100,000.00

    We propose to develop a novel reagent for nucleic acid isolation. If successfully developed, this reagent will be appropriate for use in nucleic acids isolation from a variety of sample types, includi ...

    SBIR Phase I 2005 Department of Homeland Security
  8. A Rapid, Sensitive and Fully Automated Anthrax Test

    Amount: $584,115.00

    DESCRIPTION (provided by applicant): Bioterrorism and biowarfare are a threat for our nation. Such threat became reality in the 2001 Anthrax attack. Although the attack occurred at a small scale, its ...

    SBIR Phase I 2005 Department of Health and Human Services
  9. Rapid Detection of Catheter Related Bacteraemia

    Amount: $151,662.00

    DESCRIPTION (provided by applicant): Central venous catheterization is an essential part of intensive care and cancer patient care. Approximately 5 million central venous catheters are used each year ...

    SBIR Phase I 2005 Department of Health and Human Services
  10. Rapid Detection of Bacterial Contamination in Platelets

    Amount: $99,670.00

    DESCRIPTION (provided by applicant): Sepsis resulted from transfusion of bacterially contaminated blood components, particularly platelets, is an on-going medical problem that frequently causes mortal ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government